- Home
- SBRA vs IRTC Comparison
SBRA vs IRTC Comparison
Compare SBRA & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBRA | IRTC |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.8B |
| IPO Year | 2010 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SBRA | IRTC |
|---|---|---|
| Price | $20.60 | $128.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $21.75 | ★ $209.69 |
| AVG Volume (30 Days) | ★ 2.8M | 631.6K |
| Earning Date | 05-14-2026 | 05-25-2026 |
| Dividend Yield | ★ 5.83% | N/A |
| EPS Growth | 18.52 | ★ 61.71 |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $774,632,000.00 | $747,138,000.00 |
| Revenue This Year | $6.74 | $18.26 |
| Revenue Next Year | $8.79 | $15.44 |
| P/E Ratio | $32.20 | ★ N/A |
| Revenue Growth | 10.15 | ★ 26.24 |
| 52 Week Low | $15.75 | $92.52 |
| 52 Week High | $21.07 | $210.01 |
Technical Indicators
Market Signals| Indicator | SBRA | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 64.15 | 32.65 |
| Support Level | $18.16 | N/A |
| Resistance Level | $20.70 | $167.19 |
| Average True Range (ATR) | 0.48 | 8.07 |
| MACD | 0.08 | -1.30 |
| Stochastic Oscillator | 77.28 | 11.70 |
Price Performance
Historical ComparisonAbout SBRA Sabra Health Care REIT Inc.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
About IRTC iRhythm Technologies Inc.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.